Improvement in left ventricular intrinsic dyssynchrony with cardiac resynchronization therapy
Serdar Bozyel1, Ayşen Ağaçdiken Ağır, Tayfun Şahin
1Department of Cardiology, Derince Training and Research Hospital; Kocaeli-Turkey. seribra85@gmail.com.
Anatolian Journal of Cardiology
|March 19, 2017
Summary
Cardiac resynchronization therapy (CRT) improves left ventricular (LV) contraction patterns and reduces dyssynchrony. This therapy promotes reverse remodeling, enhancing intrinsic heart function in patients with heart failure.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is known to induce structural and electrical remodeling in the left ventricle (LV).
- The association between LV reverse remodeling and the restoration of intrinsic contraction patterns following CRT remains unclear.
- Understanding these changes is crucial for optimizing CRT efficacy.
Purpose of the Study:
- To investigate the improvement in left ventricular intrinsic dyssynchrony in patients undergoing CRT.
- To determine if CRT response is linked to the restoration of the native contraction pattern.
- To evaluate the impact of CRT on electrical and mechanical dyssynchrony.
Main Methods:
- Prospective study of 45 CRT recipients.
- Measurement of dyssynchrony indexes (interventricular mechanical delay [IVMD], opposing-wall delay [OWD]) and QRS duration before and after 1 year of CRT.
- Reprogramming to VVI 40 to assess intrinsic rhythm and contraction patterns.
Main Results:
- 71% of patients responded to CRT, defined by a ≥15% reduction in LV end-systolic volume.
- Responders showed significant reductions in native QRS duration, IVMD, and OWD.
- LVESV reduction strongly correlated with improvements in OWD, IVMD, and QRS duration.
Conclusions:
- Chronic CRT significantly enhances the intrinsic contraction pattern of the left ventricle.
- CRT effectively reduces dyssynchrony and promotes reverse remodeling in responsive patients.
- Restoration of native conduction is associated with improved cardiac mechanics post-CRT.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
685
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
685
Cardiomyopathy V: Interprofessional Care
556
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
556
Cardiomyopathy III: Hypertrophic Cardiomyopathy
586
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
586
Cardiomyopathy IV: Restrictive Cardiomyopathy
688
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
688
Heart Failure Drugs: Inotropic Agents
1.7K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.7K
Heart Failure VI: Adjunct Therapies
486
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
486


